Opening Salvo Fired In Fosamax Trial

Law360, New York (August 12, 2009, 4:46 PM EDT) -- A 71-year-old woman suffering from a painful bone disease found herself painted as both innocent victim and deluded grandmother as the first of three bellwether trials over Merck & Co.'s osteoporosis drug Fosamax began in earnest on Wednesday.

After years of tangling over various pretrial matters, lawyers for Merck and plaintiff Shirley Boles finally squared off in a Manhattan courtroom to present their opening arguments following Monday's jury selection process.

Timothy O'Brien, the attorney representing Boles, kicked things off by repeating the two main points he...
To view the full article, register now.

UK Financial Services

UK Financial Services

Read Our Latest UK Financial Services Coverage

Financial Services Law360 UK provides breaking news and analysis on the financial sector. Coverage includes UK and European Union policy, enforcement, and litigation involving banks, asset management firms, and other financial services organizations.